- The
Novavax COVID-19 vaccine, sold
under the
brand names Nuvaxovid and Covovax,
among others, is a
subunit COVID-19
vaccine developed by
Novavax and the...
-
approval of its NVX-CoV2373
vaccine for COVID-19. The COVID-19
vaccine Nuvaxovid was
approved in the
European Union at the end of 2021, and in
Canada in...
- the
first recombinant protein-based COVID-19
vaccine (Novavax's
booster Nuvaxovid) was
authorized for use in
adults in the
United Kingdom. It has subsequently...
- (Human Papillomavirus), Flublok(influenza),
Shingrix (Herpes zoster) and
Nuvaxovid (Coronavirus
disease 2019).
After injection,
antigens trigger the production...
- Ltd's) COVID-19
vaccine NUVAXOVID".
Therapeutic Goods Administration. 20
January 2022.
Retrieved 20
January 2022. "Novavax
Nuvaxovid COVID-19 vaccine". Health...
- 484 Covovax/
Nuvaxovid 18 Jan 2022); (32.405 Covovax/
Nuvaxovid 16 Jan 2022); (32.514 Covovax/
Nuvaxovid 19 Jan 2022); (32.448 COVOVAX/
NUVAXOVID) 23 Jan 2022;...
-
granted interim authorization for the
Novavax vaccine under the
brand name
Nuvaxovid,
under the
Pandemic Special Access Route; it is a two-dose regimen, and...
-
nusinersen (INN)
Nutracort Nutrestore Nutrilipid Nutropin Nutropin AQ
Nuvaring Nuvaxovid nuvenzepine (INN)
Nuvion Nydrazid Nypozi Nysert Nystaform nystatin (INN)...
-
vaccine brand names Spikevax (Moderna),
Vaxzevria (AstraZeneca), and
Nuvaxovid (Novavax).
Other brands that
Brand Institute claims to have
worked on...
- from the
original on 6 May 2021.
Retrieved 6 May 2021. "EMA
recommends Nuvaxovid for
authorisation in the EU".
European Medicines Agency. 20
December 2021...
